| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.9 |
| mRNA |
681640 |
GDSC1000 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
KIN001-135 |
GDSC1000 |
pan-cancer |
AAC |
0.0096 |
0.9 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.9 |
| mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
-0.0086 |
0.9 |
| mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
-0.021 |
0.9 |
| mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.9 |